34 related articles for article (PubMed ID: 21751148)
1. Exploring Bariatric Surgery's Impact on Weight Loss and Diabetes: Sodium and Glucose Receptor Modulation.
Cottam A; Cottam D; Roslin M; Surve A
JSLS; 2024; 28(1):. PubMed ID: 38562948
[TBL] [Abstract][Full Text] [Related]
2. CircRNAs: Roles in regulating head and neck squamous cell carcinoma.
Han X; Tian R; Wang C; Li Y; Song X
Front Oncol; 2022; 12():1026073. PubMed ID: 36483049
[TBL] [Abstract][Full Text] [Related]
3. Relationships between expression of glucose transporter protein-1 and hypoxia inducible factor-1α, prognosis and
Shen LF; Zhou SH; Yu Q
Transl Cancer Res; 2020 Apr; 9(4):2824-2837. PubMed ID: 35117639
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of glycolysis markers in head and neck squamous cell carcinoma: a meta-analysis.
Wang Y; Li Y; Jiang L; Ren X; Cheng B; Xia J
Aging (Albany NY); 2021 Feb; 13(5):7284-7299. PubMed ID: 33653965
[TBL] [Abstract][Full Text] [Related]
5. Hexokinase 2 enhances the metastatic potential of tongue squamous cell carcinoma via the SOD2-H2O2 pathway.
Wang W; Liu Z; Zhao L; Sun J; He Q; Yan W; Lu Z; Wang A
Oncotarget; 2017 Jan; 8(2):3344-3354. PubMed ID: 27926482
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia promotes the invasion and metastasis of laryngeal cancer cells via EMT.
Zuo J; Wen J; Lei M; Wen M; Li S; Lv X; Luo Z; Wen G
Med Oncol; 2016 Feb; 33(2):15. PubMed ID: 26749588
[TBL] [Abstract][Full Text] [Related]
7. Expression and significance of hypoxia-inducible factor-1α and glucose transporter-1 in laryngeal carcinoma.
Wu XH; Chen SP; Mao JY; Ji XX; Yao HT; Zhou SH
Oncol Lett; 2013 Jan; 5(1):261-266. PubMed ID: 23255932
[TBL] [Abstract][Full Text] [Related]
8. Expression of glucose transporters and hexokinase II in cholangiocellular carcinoma compared using [18F]-2-fluro-2-deoxy-D-glucose positron emission tomography.
Paudyal B; Oriuchi N; Paudyal P; Higuchi T; Nakajima T; Endo K
Cancer Sci; 2008 Feb; 99(2):260-6. PubMed ID: 18271924
[TBL] [Abstract][Full Text] [Related]
9. The Role of Glucose Transporters in Oral Squamous Cell Carcinoma.
Botha H; Farah CS; Koo K; Cirillo N; McCullough M; Paolini R; Celentano A
Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439735
[TBL] [Abstract][Full Text] [Related]
10. GLUT and HK: Two primary and essential key players in tumor glycolysis.
Yadav D; Yadav A; Bhattacharya S; Dagar A; Kumar V; Rani R
Semin Cancer Biol; 2024 May; 100():17-27. PubMed ID: 38494080
[TBL] [Abstract][Full Text] [Related]
11. Expression and prognostic value of glucose transporters and hexokinases in tonsil and mobile tongue squamous cell carcinoma.
Deron P; Vermeersch H; Mees G; Vangestel C; Pauwels P; Van de Wiele C
Histol Histopathol; 2011 Sep; 26(9):1165-72. PubMed ID: 21751148
[TBL] [Abstract][Full Text] [Related]
12. Expression of glucose transporter-1, hexokinase-II, proliferating cell nuclear antigen and survival of patients with pancreatic cancer.
Lyshchik A; Higashi T; Hara T; Nakamoto Y; Fujimoto K; Doi R; Imamura M; Saga T; Togashi K
Cancer Invest; 2007; 25(3):154-62. PubMed ID: 17530485
[TBL] [Abstract][Full Text] [Related]
13. FDG uptake in primary squamous cell carcinoma of the head and neck. The relationship between overexpression of glucose transporters and hexokinases, tumour proliferation and apoptosis.
Deron P; Vangestel C; Goethals I; De Potter A; Peeters M; Vermeersch H; Van de Wiele C
Nuklearmedizin; 2011; 50(1):15-21. PubMed ID: 21052609
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
